ATE218345T1 - Arzneimittel gegen spinocerebellare degeneration - Google Patents

Arzneimittel gegen spinocerebellare degeneration

Info

Publication number
ATE218345T1
ATE218345T1 AT95927966T AT95927966T ATE218345T1 AT E218345 T1 ATE218345 T1 AT E218345T1 AT 95927966 T AT95927966 T AT 95927966T AT 95927966 T AT95927966 T AT 95927966T AT E218345 T1 ATE218345 T1 AT E218345T1
Authority
AT
Austria
Prior art keywords
represent
spinocerebellar degeneration
drugs
ococh3
hydrogen
Prior art date
Application number
AT95927966T
Other languages
English (en)
Inventor
Tetsuo Sakai
Yasunobu Antoku
Toyojiro Matsuishi
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ATE218345T1 publication Critical patent/ATE218345T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT95927966T 1994-08-05 1995-08-04 Arzneimittel gegen spinocerebellare degeneration ATE218345T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18468294 1994-08-05
PCT/JP1995/001550 WO1996003989A1 (en) 1994-08-05 1995-08-04 Remedy for spinocerebellar degeneration

Publications (1)

Publication Number Publication Date
ATE218345T1 true ATE218345T1 (de) 2002-06-15

Family

ID=16157531

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95927966T ATE218345T1 (de) 1994-08-05 1995-08-04 Arzneimittel gegen spinocerebellare degeneration

Country Status (6)

Country Link
US (1) US5753656A (de)
EP (1) EP0722731B1 (de)
AT (1) ATE218345T1 (de)
DE (1) DE69526918T2 (de)
ES (1) ES2177654T3 (de)
WO (1) WO1996003989A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4418097A1 (de) 1994-05-24 1995-11-30 Cassella Ag Verwendung von Tetrahydropteridin-Derivaten als Hemmstoffe der NO-Synthase
KR19990063880A (ko) * 1996-07-31 1999-07-26 나카무라 게이코 프테린 유도체 함유 활성산소 제거제
ATE252385T1 (de) 1996-08-30 2003-11-15 Daiichi Suntory Pharma Co Ltd Vorbeugende oder heilende mittel für krankheiten, die durch mangel an stickoxid-synthase (nos) ausgelöst sind
JP4306825B2 (ja) 1998-02-27 2009-08-05 アスビオファーマ株式会社 インスリン抵抗性が関与する血管機能異常を伴う疾患の予防または治療剤
US7610233B1 (en) 1999-12-22 2009-10-27 Accenture, Llp System, method and article of manufacture for initiation of bidding in a virtual trade financial environment
US7167844B1 (en) 1999-12-22 2007-01-23 Accenture Llp Electronic menu document creator in a virtual financial environment
US6623754B2 (en) * 2001-05-21 2003-09-23 Noveon Ip Holdings Corp. Dosage form of N-acetyl cysteine
US20060110325A1 (en) * 2003-02-21 2006-05-25 Hinz Martin C Serotonin and catecholamine segment optimization technology
US20070293571A1 (en) * 2006-06-08 2007-12-20 Hinz Martin C Adminstration of dopa precursors with sources of dopa to effectuate optimal catecholamine neurotransmitter outcomes
EP1490073A4 (de) * 2002-03-21 2006-02-01 Martin C Hinz Segmentoptimierungstechnik für das serotonin- und catecholamin-system
US20090311795A1 (en) * 2002-03-21 2009-12-17 Hinz Martin C Bilateral control of functions traditionally regulated by only serotonin or only dopamine
DE10260263A1 (de) * 2002-12-20 2004-07-15 Biocrates Life Sciences Gmbh Verwendung von Tetrahydrobiopterinderivaten zur Behandlung und Ernährung von Patienten mit Aminosäurestoffwechselstörungen
US7442372B2 (en) 2003-08-29 2008-10-28 Biomarin Pharmaceutical Inc. Delivery of therapeutic compounds to the brain and other tissues
US7906520B2 (en) * 2003-11-13 2011-03-15 The General Hospital Corporation Methods for treating pain
PT3138566T (pt) * 2003-11-17 2022-02-02 Biomarin Pharm Inc Tratamento de fenilcetonúria com bh4
CA2566433C (en) * 2004-05-11 2013-02-19 Daiichi Asubio Pharma Co., Ltd. Therapeutic agent for bh4-responsive hyperphenylalaninemia
EP2436379A1 (de) * 2004-11-17 2012-04-04 BioMarin Pharmaceutical Inc. Stabile Tablettenformulierung
US20100130500A1 (en) * 2004-12-08 2010-05-27 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of pulmonary hypertension of the newborn
AU2006321942A1 (en) * 2005-12-05 2007-06-14 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of disease
WO2008089148A1 (en) * 2007-01-12 2008-07-24 Biomarin Pharmaceutical Inc. Method of treating a metabolic or neuropsychiatry disorder with a bh4 derivative prodrug
CA2675134A1 (en) * 2007-01-12 2008-07-24 Biomarin Pharmaceutical Inc. Pterin analogs
JP2010523708A (ja) 2007-04-11 2010-07-15 バイオマリン ファーマシューティカル インコーポレイテッド テトラヒドロビオプテリンを投与する方法、関連する組成物および測定方法
MX2010006025A (es) * 2008-01-03 2010-06-30 Biomarin Pharm Inc Analogo de pterina para tratar afeccion sensible a bh4.
WO2011132435A1 (ja) 2010-04-22 2011-10-27 学校法人日本大学 脳機能障害予防・改善用の薬剤及び飲食物
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
CA3043499A1 (en) 2016-11-29 2018-06-07 Censa Pharmaceuticals Inc. Polymorphic form of sepiapterin
US11072614B2 (en) 2016-11-29 2021-07-27 Ptc Therapeutics Mp, Inc. Polymorphs of sepiapterin and salts thereof
AU2018277981B2 (en) * 2017-06-02 2021-04-08 Fujifilm Toyama Chemical Co., Ltd. Agent for preventing or treating spinocerebellar ataxia
WO2019046849A1 (en) 2017-09-01 2019-03-07 Censa Pharmaceuticals Inc. PHARMACEUTICAL COMPOSITION COMPRISING SEPAPTERINE AND USES THEREOF
MX2020012978A (es) * 2018-05-30 2021-04-28 Ptc Therapeutics Mp Inc Sales de sepiapterina farmacéuticamente aceptables.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925323A (ja) * 1982-03-03 1984-02-09 鐘淵化学工業株式会社 プテリン誘導体からなる脳内神経伝達物質の関わる疾病の治療剤
ZA836957B (en) * 1982-09-20 1985-04-24 Wellcome Found Neurologically active chemical compounds
JPS61277618A (ja) * 1985-06-04 1986-12-08 Suntory Ltd 自閉症治療剤
JP2588191B2 (ja) * 1987-04-24 1997-03-05 サントリー株式会社 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤
ATE180493T1 (de) * 1991-11-16 1999-06-15 Suntory Ltd Rezeptor für 6(r)-l-erythro-5,6,7,8- tetrahydrobiopterin

Also Published As

Publication number Publication date
WO1996003989A1 (en) 1996-02-15
EP0722731A1 (de) 1996-07-24
DE69526918T2 (de) 2002-12-19
DE69526918D1 (de) 2002-07-11
EP0722731A4 (de) 1998-03-04
ES2177654T3 (es) 2002-12-16
US5753656A (en) 1998-05-19
EP0722731B1 (de) 2002-06-05

Similar Documents

Publication Publication Date Title
ATE218345T1 (de) Arzneimittel gegen spinocerebellare degeneration
DE69831868D1 (en) Antithrombosemittel
AU8794291A (en) New oxazolopyridine derivatives, processes for preparing these and pharmaceutical compositions containing them
AU7278500A (en) Fungicides
AU1608692A (en) Amidinophenylalanine derivatives, a process for the preparation thereof, use thereof and agents containing these as anticoagulants
PT928788E (pt) Compostos farmaceuticamente activos
EP0630898A4 (de) Heilmittel für thrombozytopenia.
CA2336412A1 (en) Medicament for treatment of diabetes
EP1182193A4 (de) Medikamente gegen neuropathische schmerzen
ES2072223B1 (es) Liposomas encapsulando doxorubicina.
IL114785A0 (en) Pyrrolocarbazoles their preparation and pharmaceutical compositions containing them
HUT59139A (en) Process for producing tricyclic compounds and antimicrobial pharmaceutical compositions comprising same
EP0754683A4 (de) Etherverbindungen, ihre verwendung und zwischenprodukte zu ihrer herstellung
WO2000046210A3 (en) New process for preparing pesticidal intermediates
EP0712398A1 (de) Benzopyrane und diese enthaltende pharmazeutische zusammenstellungen
IL166513A0 (en) Lamellarin derivatives and pharmaceutical compositions containing the same
EP0816366A4 (de) Imidazothiazolverbindungen
DE69722610D1 (de) Neue Inhalationspräparate enthaltend CR 2039 (Andolast)
MX9206930A (es) Nuevos compuestos
EP1026162A4 (de) Antirheumatika
FI911138A0 (fi) Ny substituerad aminfoerening och foerfarande foer dess framstaellning.
DE69925225D1 (de) Propylaxe und behandlung der arzneimittel induzierten nierenstörungen
AU4732096A (en) Remedy for pulmonary heart
EP0773019A4 (de) Medikament gegen hyperlipämie
EP0358091A3 (de) 2-Zyklohexylpropanal-Derivate und diese enthaltende Parfümeriezusammenstellungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties